209 related articles for article (PubMed ID: 19158035)
1. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
Ademuyiwa FO; Miller KD
Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapies in breast cancer.
Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G
Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitors in the management of breast cancer.
Bossung V; Harbeck N
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):79-86. PubMed ID: 19952746
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
Morabito A; Sarmiento R; Bonginelli P; Gasparini G
Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer: the role of angiogenesis and antiangiogenic therapy.
Miller KD; Dul CL
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1071-86, ix. PubMed ID: 15474336
[TBL] [Abstract][Full Text] [Related]
6. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
Gagne P; Akalu A; Brooks PC
Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy in the management of breast cancer.
Wu Y; Sun WL; Feng JF
Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic strategies in breast cancer management.
Giovannini M; Aldrighetti D; Zucchinelli P; Belli C; Villa E
Crit Rev Oncol Hematol; 2010 Oct; 76(1):13-35. PubMed ID: 20702105
[TBL] [Abstract][Full Text] [Related]
9. Targeting angiogenesis with integrative cancer therapies.
Yance DR; Sagar SM
Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
[TBL] [Abstract][Full Text] [Related]
10. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
Lyons JM; Anthony CT; Thomson JL; Woltering EA
Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
[TBL] [Abstract][Full Text] [Related]
11. The combination of antiangiogenic therapy with other modalities.
O'Reilly MS
Cancer J; 2002; 8 Suppl 1():S89-99. PubMed ID: 12075706
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenesis: the fifth cancer treatment modality?
Camp-Sorrell D
Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic events in patients with cancer receiving antiangiogenesis agents.
Zangari M; Fink LM; Elice F; Zhan F; Adcock DM; Tricot GJ
J Clin Oncol; 2009 Oct; 27(29):4865-73. PubMed ID: 19704059
[TBL] [Abstract][Full Text] [Related]
15. Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
Miller KD
Breast Cancer Res; 2004; 6(3):128-32. PubMed ID: 15084233
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic therapy for cancer: an update.
Shojaei F; Ferrara N
Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic drugs in ovarian cancer.
Markman M
Expert Opin Pharmacother; 2009 Oct; 10(14):2269-77. PubMed ID: 19671017
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets for breast cancer therapy and prevention.
Bange J; Zwick E; Ullrich A
Nat Med; 2001 May; 7(5):548-52. PubMed ID: 11329054
[TBL] [Abstract][Full Text] [Related]
19. Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy.
Mazeron R; Anderson B; Supiot S; Paris F; Deutsch E
Cancer Treat Rev; 2011 Oct; 37(6):476-86. PubMed ID: 21546163
[TBL] [Abstract][Full Text] [Related]
20. Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?
Bozza C; Fontanella C; Buoro V; Mansutti M; Aprile G
Expert Rev Clin Pharmacol; 2015 Mar; 8(2):251-65. PubMed ID: 25597501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
